Carvedilol in elderly patients with chronic heart failure, a 12 weeks randomized, placebo controlled open trial

Archives of Gerontology and Geriatrics

Volumn 29, Issue 3, 2000, Pages 275-282

  Leonetti Luparini, Riccardo ^a   Celli, Valdisa ^a   Piccirillo, Gianfranco ^a   Guidi, Virgilio ^a   Cacciafesta, Mauro ^a   Marigliano, Vincenzo ^a  

^a POLICLINICO UMBERTO I   (Italy)

Author keywords

adrenergic blockade; Elderly subjects; Heart failure

Indexed keywords

CARVEDILOL; DIGITALIS; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; FUROSEMIDE; PLACEBO;

ADULT; ARTICLE; BLOOD PRESSURE; CLINICAL ARTICLE; CLINICAL TRIAL; COGNITION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; FEMALE; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART RATE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME;

DIGITALIS;

EID: 0011446022     PISSN: 01674943     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0167-4943(99)00040-0     Document Type: Article

References (15)

1. Effects of carvedilol, a vasodilator-β-blocker, in patients with congestive heart failure due to ischaemic heart disease. Circulation. 92:1995;212-218.
2. Randomised, placebo-controlled trial of carvedilol in patients with congestive heart failure due to ischaemic heart disease. Lancet. 349:1997;375-380.
3. Cohn J.N., Fowler M.B., Bristow M.A., Colucci W.S., Gilbert E.M., Kinal V., Krueger S.K., LeJemtel T., Narahara K.A., Packer M. Effect of carvedilol in severe heart failure. J. Am. Coll. Cardiol. 26:1996;169A.
4. Cohn J.N., Fowler M.B., Bristow M.R., Colucci W.S., Gilbert E.M., Kinhal V., Krueger S.K., Lejemtel T., Narahara K.A., Packer M., Young S.T., Holcslaw T.L., Lukas M.A. Safety and efficacy of carvedilol in severe heart failure. The U.S. Carvedilol Heart Failure Study Group. J. Card. Fail. 3:1997;173-179.
5. Doughty R.N., Whalley G.A., Gahble G., MacMahon S., Sharpe N. Left ventricular remodeling with carvedilol in patients with congestive heart failure due to ischemic heart disease. J. Am. Coll. Cardiol. 29:1997;1060-1066.
6. Folstein M.F., Folstein S.E., Mc Hugh P.R. Mini-mental state. A practical method for grading the cognitive state of patients for the clinician. J. Psychiatry Res. 3:1975;189-198.
7. Katz S., Downs T.D., Cash H.R., Grotz R.C. Progress in development of the index of ADL. Gerontologist. 1:1970;20-30.
8. Lawton M.P., Brody E.M. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist. 3:1969;179-186.
9. Metra M., Nardi M., Giubbini R., Dei Cas L. Effects of short- and long-term carvedilol administration on rest and exercise hemodynamic variables, exercise capacity and clinical conditions in patients with idopathic dilated cardiomyopathy. J. Am. Coll. Cardiol. 24:1994;1678-1687.
10. Olsen S.L., Gilbert E.M., Renlund D.G., Taylor D.O., Yanowitz F.D. Carvedilol improves left ventricular function and symptoms in chronic heart failure: a double-blind randomized study. J. Am. Coll. Cardiol. 25:1995;1225-1231.
11. Packer M., Bristow M.R., Cohn J.N., Colucci W.S., Fowler M.B., Gilbert E.M., Shusterman N.H. The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. N. Engl. J. Med. 334:1996;1349-1355.
12. Swedberg K., Hjalmarson A., Waagstein F., Wallentin I. Prolongation of survival in congestive cardiomyopathy by β-receptor blockade. Lancet. 1:1979;1374-1376.
13. Diseases of the Heart and Blood Vessels: Nomenclature and Criteria for Diagnosis. 6th ed. 1964;New York Heart Association/Little, Brown and Co, New York.
14. Waagstein F., Hjalmarson A., Wasis H.S. Apex cardiogram and systolic time intervals in acute myocardial infarction and effect of pratolol. Br. Heart. J. 36:1974;1109.
15. Waagstein F., Hjalmarson A., Varnauskas E., Wallentin I. Effect of chronic β-adrenergic receptor blockade in congestive cardiomyopathy. Br. Heart. J. 37:1975;1022-1036.